Diabetes complications

Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease

JAMA Netw OpenPublished Cohort study

Authors' conclusion

In this cohort study of patients with hypertension or diabetes, it was estimated that approximately two-thirds of patients with albuminuria were undetected due to lack of testing. These results suggest that improving detection of CKD with albuminuria testing represents a substantial opportunity to optimize care delivery for reducing CKD progression and cardiovascular complications.

Study context

Population
US adults with hypertension or diabetes, active outpatients in Optum deidentified electronic health record (EHR) data set; mean age 60.3 years, 96.6% hypertension, 26.2% diabetesEHR population
Participants
192,108 adults
Exposure
Albuminuria testing vs no testing
  • Testedn = 33,629
  • Untestedn = 158,479reference
Outcome
Prevalence of albuminuria (urine albumin-creatinine ratio ≥30 mg/g) among tested and untested patients
Follow-up
January 1, 2017, to December 31, 2018
Methodological detailsNational Health and Nutrition Examination Surveys (NHANES)-derived logistic regression model applied to EHR data
  • NHANES-derived logistic regression model applied to EHR data

Main finding

As reported in the abstract

Albuminuria prevalence
Projected population with albuminuria who had been tested
35.2% (11 525 of 32 756)

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)
CKD therapies within subsequent year, by albuminuria testing (adjusted)Testedvs UntestedACEi or ARB treatment · multivariable logistic regression2.39 (2.32–2.46)
CKD therapies within subsequent year, by albuminuria testing (adjusted)Testedvs UntestedSGLT2i treatment · multivariable logistic regression8.22 (7.56–8.94)
CKD therapies within subsequent year, by albuminuria testing (adjusted)Testedvs UntestedBP controlled to <140/90 mm Hg · multivariable logistic regression1.20 (1.16–1.23)

Original publication

Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease. JAMA Netw Open. Published 3 July 2023. doi:10.1001/jamanetworkopen.2023.26230

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.